These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17121486)

  • 1. Psoriatic arthritis update.
    Mease P
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):25-31. PubMed ID: 17121486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic arthritis treatment: biological response modifiers.
    Mease PJ; Antoni CE
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii78-82. PubMed ID: 15708944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus exercise on domains in psoriatic arthritis.
    Gladman DD
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii113-4. PubMed ID: 15708924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis: update on pathophysiology, assessment and management.
    Mease PJ
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic arthritis assessment and treatment update.
    Mease PJ
    Curr Opin Rheumatol; 2009 Jul; 21(4):348-55. PubMed ID: 19461518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis - update on pathophysiology, assessment, and management.
    Mease PJ
    Bull NYU Hosp Jt Dis; 2010; 68(3):191-8. PubMed ID: 20969551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist.
    Ruderman EM; Tambar S
    Dermatol Clin; 2004 Oct; 22(4):477-86, x. PubMed ID: 15450343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite measures in psoriatic arthritis: GRAPPA 2008.
    Gladman DD; Landewé R; McHugh NJ; Fitzgerald O; Thaci D; Coates L; Mease PJ; Qureshi AA; Krueger GG; Ritchlin CT; Kavanaugh AF; Garg A
    J Rheumatol; 2010 Feb; 37(2):453-61. PubMed ID: 20147481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriatic arthritis with biological agents.
    Ceponis A; Kavanaugh A
    Semin Cutan Med Surg; 2010 Mar; 29(1):56-62. PubMed ID: 20430309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on treatment of psoriatic arthritis.
    Mease P
    Bull NYU Hosp Jt Dis; 2012; 70(3):167-71. PubMed ID: 23259623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic issues in psoriatic arthritis.
    Olivieri I; D'Angelo S; Palazzi C; Padula A; Lubrano E; Mantovani LG
    J Rheumatol Suppl; 2012 Jul; 89():103-5. PubMed ID: 22751607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arthritis psoriatica].
    de Rie MA; van Kuijk AW; Goedkoop AY; Tak PP
    Ned Tijdschr Geneeskd; 2007 Aug; 151(31):1716-22. PubMed ID: 17784693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis.
    Punzi L; Podswiadek M; Sfriso P; Oliviero F; Fiocco U; Todesco S
    Autoimmun Rev; 2007 Sep; 6(8):524-8. PubMed ID: 17854743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.